News | News By Subject | News by Disease News By Date | Search News

Breast Cancer News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
Genentech (RHHBY) Quietly Shelves Phase II Cancer Contender     4/27/2017
Former Pfizer (PFE) Cancer Scientist Gets All 5 Papers Retracted     4/24/2017
AbbVie (ABBV)'s PARP Inhibitor Fails to Deliver in Two Late-Stage Studies     4/20/2017
FDA's Shorten Review Time is a Bad Sign for Puma Biotech (PBYI)'s Controversial Cancer Drug     4/20/2017
Investors Squeal With Delight as Eli Lilly (LLY)'s Breast Cancer Combo Succeeds in Phase III, Faces Tough Competition from Pfizer (PFE) and Novartis AG (NVS)     3/21/2017
Genentech (RHHBY) New Breast Cancer Cocktail Cuts Deaths in Phase III Study, Roche (RHHBY) Stock Soars     3/3/2017
AstraZeneca PLC (AZN) Investors Pumped as Breast Cancer Drug Sails Through Phase III Trial     2/20/2017
Roche (RHHBY) Faces Off With Itself for $9 Billion Breast Cancer Drug Business     2/15/2017
Merrimack (MACK) Halts Phase II HERMIONE Study for Breast Cancer; Further Plans Revealed in January     12/22/2016
Celgene (CELG) Decides to Not Move Forward With Phase III Portion of tnAcity     12/7/2016
NICE U-Turns and Backs Approval of Roche (RHHBY)'s Perjeta for HER2-Positive Breast Cancer     11/22/2016
Puma Biotech (PBYI) Crashes After Diarrhea Risk is Linked to Breast Cancer Drug in Abstract     11/16/2016
Eli Lilly (LLY)'s Breast Cancer Drug Failed to Meet Phase III Goals, But Panel Recommends Continuation of Trial     8/10/2016
FDA Bestows Novartis AG (NVS)'s Breast Cancer Pill With Breakthrough Tag     8/3/2016
Amgen (AMGN) And Allergan (AGN) Biosimilar Found as Effective as Genentech (RHHBY)'s Herceptin     7/21/2016

News from Around the Web
Researchers Create New Diagnostic Tool For Detecting Breast Cancer, Simon Fraser University Study Reveals     4/7/2017
Sought-After Tesaro (TSRO) Sees A $5 Billion Opportunity For Its Cancer Drug     2/17/2017
Scalp Cooling Device May Help Reduce Hair Loss For Women With Breast Cancer On Chemotherapy, JAMA Reveals     2/15/2017
Biggest Breast Cancer Breakthrough: Map Links Cell Shape And Genes To Disease Outcomes, Institute of Cancer Research in London Study     2/6/2017
Were Women Foolish To Follow Angelina Jolie Into BRCA Cancer Gene Testing?     1/5/2017
Breast Cancer Cells Do Not Like It Spicy, Ruhr-University Study     12/22/2016
How 3 Huge Discoveries in 2016 are Moving Us Closer to a Breast Cancer Cure     10/24/2016
Puma Biotech (PBYI)'s $150 Million Stock Offering May Signal to Investors That Its Breast Cancer Drug is in Trouble     10/20/2016
Mammograms More Likely To Cause Unneeded Treatment Than To Save Lives, Published In BMJ     10/13/2016
Newly Developed: Non-Invasive, Safe Tester For Breast Cancer Diagnosis, Polish Biotech Braster Reveals     10/7/2016
Implant Improves Breast Cancer Survival, University of Michigan Study     9/30/2016
Want A BRCA Test? Some Insurers Require Genetic Counseling First     9/19/2016
Simple Blood Test Could Be Used To Detect Breast Cancer, University of Western Australia Study     9/9/2016
New Platform Hopes To Speed Diagnosis Of Parkinson's Disease And Breast Cancer, Oxford Impedance Diagnostics Reveals     8/1/2016
New Review Concludes Evidence For Alcohol Causing Cancer Is Strong, University Of Otago Study     7/22/2016

Press Releases
Invitae Release: New Research Suggests Current Genetic Testing Guidelines May Miss Breast Cancer Patients Who Could Benefit From Testing     4/28/2017
Blaze Bioscience Announces Presentation Of Tumor Paint BLZ-100 Clinical Data At American Society of Breast Surgeons (ASBrS) Annual Meeting     4/27/2017
Eli Lilly (LLY) Finally Catches A Break With Encouraging Phase III Breast Cancer Data     4/24/2017
HTG Molecular Diagnostics And Instituto Valenciano De OncologĂ­a Initiate Breast Cancer Recurrence Risk Collaboration     4/24/2017
GRAIL Initiates The STRIVE Study To Advance Development Of Blood Tests To Detect Cancer Early     4/20/2017
GNT Biotech and Medicals Corporation To Begin Phase III Clinical Trial In Taiwan Of Epigenetic Regulator Chidamide For Late-Stage Breast Cancer     4/19/2017
Goodwin Biotechnology, Inc. Release: Finding Solutions That Help A Unique Monoclonal Antibody Advance The Fight Against Metastatic Breast Cancer     4/19/2017
Puma Biotech (PBYI) Announces FDA Advisory Committee To Review Neratinib For The Extended Adjuvant Treatment Of HER2-Positive Early Stage Breast Cancer     4/17/2017
CASI Pharma (CASI) Reports On Enrollment Status Of ENMD-2076 Phase II Study In Triple-Negative Breast Cancer     4/14/2017
Oncolytics Biotech (ONC.TO) Announces Registration Pathway And Clinical Development Plan     4/12/2017
Cancer Prevention Institute Of California Release: Breast Cancer Rates Increasing Among Asian Americans     4/11/2017
Lund University Includes DiviTum In Study For Treatment Efficacy Evaluation Of Breast Cancer Patients     4/11/2017
Researchers Create New Diagnostic Tool For Detecting Breast Cancer, Simon Fraser University Study Reveals     4/7/2017
Innocrin Appoints Fred Eshelman, Pharmd As CEO And Is Granted Fast Track Designation By FDA For Seviteronel Treatment Of Women With Triple-Negative Breast Cancer And Women Or Men With Estrogen Receptor-Positive Breast Cancer     4/6/2017
Theraclion Release: Long-Term Results Show Substantial Enduring Effect For Non-Invasive Treatment Of Benign Breast Tumors     4/6/2017